Artem Smirnov
Post-doctoral Fellow
I received my BSc and MSc in biotechnology from the Institute of Technology, St. Petersburg, Russia, where I worked under supervision of Prof Nick A Barlev. My theses were focused on the generation of test-systems to screen for inhibitors of the p53/Mdm2 interaction. After this, I moved to Gerry Melino’s lab at the University of Rome “Tor Vergata”, Italy. There I got my PhD working with Prof Eleonora Candi. The major topic of our research was the investigation of the role of p63 in regulation of keratinocyte differentiation and proliferation, as well as its involvement in epithelial cancer. In 2019 I started my postdoc in Xin Lu’s lab in Oxford where I work on the re-activation of EBV in epithelial cancer.
Recent publications
-
Transglutaminase 3 reduces the severity of psoriasis in imiquimod‐treated mouse skin
Journal article
Piro MC. et al, (2020), International Journal of Molecular Sciences, 21
-
Long non‐coding RNA uc.291 controls epithelial differentiation by interfering with the ACTL6A/BAF complex
Journal article
Panatta E. et al, (2020), EMBO reports
-
ZNF281/Zfp281 is a target of miR-1 and counteracts muscle differentiation.
Journal article
Nicolai S. et al, (2019), Molecular oncology
-
p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer
Journal article
Smirnov A. et al, (2019), International Journal of Molecular Sciences, 20, 5781 - 5781
-
Multi-omics profiling of calcium-induced human keratinocytes differentiation reveals modulation of unfolded protein response signalling pathways.
Journal article
Anna M. et al, (2019), Cell Cycle